ESP prostheses training program
12 July 2024 - 2:30AM
UK Regulatory
ESP prostheses training program
Press
release Ecully,
July 11, 2024 – 6.30 p.m.
Spineway organizes hands-on training on
total disc replacement with its ESP prostheses at IRCAD in
Strasbourg
The Spineway Group, a specialist in innovative
implants for the treatment of severe spine disorders, organized a
hands-on training workshop entitled “Hands-on Total Disc
Replacement featuring ESP technology” at the Institut de Recherche
contre les Cancers de l’Appareil Digestif (IRCAD) in Strasbourg on
June 28, 2024. During the event, Spineway’s ESP prostheses
(cervical and lumbar) were presented to 25 surgeons and
professionals, with a presentation of the products, their
indications and two surgical approach sessions.
The training workshops took place at IRCAD in
Strasbourg, renowned for the quality of its facilities and were led
by renowned surgeons, Dr. Biren Desai (Germany), Dr. Olivier
Ricart (Luxembourg) and Pr. Marc Antoine Rousseau (Paris).
During these hands-on workshops, Spineway had three tables
dedicated to training surgeons in total disc replacement, with its
cervical (CP-ESP) and lumbar (LP-ESP) prostheses.
These training courses, highly appreciated by
surgeons, allow professionals to study and practice different
surgical approaches in order to learn or perfect their technique.
The workshop was attended by nine international surgeons who were
divided into groups of three on each table to ensure optimal
training time for each participant. Participants came from Spain,
Malaysia, Greece, the United Arab Emirates, Tunisia, France and
Germany, reflecting the international scope of the event. Some were
accompanied by their distributors, bringing the total number of
participants to 25. Spineway teams were also present, including
Stéphane Le Roux (CEO), Fabrice Paccagnella (Sales Director),
Mélody Ourdouillié (Medical Education), Loïc Aden (Product
Manager), Inès Khaoua and Yiyi Li (Sales).
The event was an opportunity to create or
strengthen ties between new and future users of Spineway products
and training surgeons, while supporting the Group’s distributors in
their training initiatives.
In line with its strategy, Spineway
aims to develop and reinforce the number of such training courses
in order to strengthen its reputation among spine surgeons. The
Group confirms its aim of becoming a
major player in less invasive spine treatments.
Next
event:
July 15, 2024 – H1 2024 revenue
SPINEWAY IS ELIGIBLE FOR PEA-SME
(EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.
Spineway has an international network of independent
distributors and derives more than 70% of its revenue from
exports.
ISIN: FR001400BVK2 –
ALSPW
Contacts:
SPINEWAY GROUP
Shareholder-services line
Available Tuesday through Thursday
+33 (0)806 706 060 |
Eligible PEA / PME
ALSPW
Euronext Growth
|
AELIUM
Finance & Ciommunication
Investor relations
Solène Kennis
spineway@aelium.fr |